Product Description

🔹 Product Overview
BEVATAS 400 mg Injection is a anticancer targeted therapy medicine containing Bevacizumab 400 mg. It belongs to a class of medicines known as anti-VEGF (vascular endothelial growth factor) monoclonal antibodies. It is used in the treatment of various cancers by slowing down the formation of new blood vessels that supply nutrients to cancer cells.
BEVATAS 400 mg Injection is administered through intravenous infusion by a qualified healthcare professional and is used as part of a cancer treatment plan under the supervision of an oncologist.

🔹 Key Uses
BEVATAS 400 mg Injection may be prescribed for:
Treatment of colorectal cancer
Management of non-small cell lung cancer (NSCLC)
Treatment of kidney cancer (renal cell carcinoma)
Management of ovarian and cervical cancers
Treatment of certain brain tumors such as glioblastoma
Used in combination with chemotherapy or other anticancer therapies as recommended by an oncologist

🔹 Composition
Active Ingredient: Bevacizumab 400 mg
Drug Class: Monoclonal Antibody
Anti-VEGF Targeted Cancer Therapy
Dosage Form: Concentrate for Intravenous Infusion

🔹 How It Works
BEVATAS 400 mg Injection contains Bevacizumab, which targets vascular endothelial growth factor (VEGF), a protein responsible for the growth of new blood vessels.
By blocking VEGF activity:
It reduces the formation of new blood vessels around tumors.
Limits the oxygen and nutrient supply available to cancer cells.
Helps slow tumor growth and progression.

🔹 Key Benefits
Targeted treatment approach for certain cancers
Helps slow cancer cell growth by reducing tumor blood supply
Used in established oncology treatment protocols
May improve treatment outcomes when combined with chemotherapy
Administered under specialist medical supervision for controlled therapy

🔹 Dosage and Administration
Use only as prescribed by an oncologist.
Administered by intravenous infusion in a hospital or oncology clinic.
Dosage depends on:
Type and stage of cancer
Body weight
Overall health condition
Other medicines used in the treatment plan
Treatment schedule is decided by the treating doctor.
Regular monitoring is required during therapy.

🔹 Possible Side Effects
Like all anticancer medicines, BEVATAS 400 mg Injection may cause side effects.
Common side effects include:
High blood pressure
Fatigue
Headache
Loss of appetite
Nausea and vomiting
Diarrhea
Mouth sores
Weakness
Low blood cell counts (when combined with chemotherapy)
Serious side effects may include:
Severe bleeding
Blood clots
Delayed wound healing
Gastrointestinal perforation (rare)
Kidney-related problems
Severe allergic reactions
Seek immediate medical attention if unusual bleeding, chest pain, severe abdominal pain, or breathing difficulty occurs.

🔹 Precautions
Use only under the supervision of an experienced oncologist.
Inform your doctor if you have:
High blood pressure
Bleeding disorders
Heart disease
Kidney problems
Recent surgery or planned surgery
Avoid pregnancy during treatment and use effective contraception if advised.
Inform your doctor about all medicines, supplements, and herbal products you use.
Blood pressure and laboratory tests may be monitored regularly.